| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/19/2001 | US20010008936 Oligonucleotides having chiral phosphorus linkages |
| 07/19/2001 | US20010008905 Administering a compound such as hydroxyurea to deplete the intracellular pool of deoxyribonucleoside phosphate |
| 07/19/2001 | US20010008634 Bactericides, fungicides, insecticides |
| 07/19/2001 | US20010008627 Controlling cell accumulation |
| 07/19/2001 | CA2823768A1 Hybrid cells |
| 07/19/2001 | CA2397575A1 Antibacterial agents |
| 07/19/2001 | CA2397481A1 Irak-4: compositions and methods of use |
| 07/19/2001 | CA2397396A1 Methods and compositions for obtaining disease protection for animals |
| 07/19/2001 | CA2397386A1 The parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
| 07/19/2001 | CA2397345A1 Arylsulfonic acid salts of pyrimidine-based antiviral agents |
| 07/19/2001 | CA2397340A1 Drug metabolizing enzymes |
| 07/19/2001 | CA2397092A1 Processes for preparing clarithromycin polymorphs |
| 07/19/2001 | CA2397081A1 Novel vitamin d analogues |
| 07/19/2001 | CA2397068A1 Pharmaceutical and cosmetic carrier or composition for topical application |
| 07/19/2001 | CA2396966A1 Methods for synthesis of .alpha.-d-gal (1.fwdarw.3) gal-containing oligosaccharides |
| 07/19/2001 | CA2396560A1 Tricyclic compounds and method of treating herpes virus |
| 07/19/2001 | CA2396384A1 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent |
| 07/19/2001 | CA2396368A1 Use of a composition comprising two quaternary ammonium compounds and an organometallic compound for treating viral and fungal infections and diseases |
| 07/19/2001 | CA2396071A1 Thickened oil compositions of edible oil |
| 07/19/2001 | CA2395975A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/19/2001 | CA2394833A1 Derivatives of polyene macrolides and preparation and use thereof |
| 07/19/2001 | CA2366599A1 Treatment of hepatitis c using hyperthermia |
| 07/18/2001 | EP1116715A1 Tetramic acid derivatives useful in medicines and foodstuffs |
| 07/18/2001 | EP1116516A1 Templating of solid particles by polymer multilayers |
| 07/18/2001 | EP1116487A2 Reduction of postoperative complications of cardiopulmonary bypass (CPB) surgery |
| 07/18/2001 | EP1116028A1 Ndp |
| 07/18/2001 | EP1115882A1 Production and use of antimicrobial agents |
| 07/18/2001 | EP1115879A1 Retroviral particles protected against complement mediated destruction |
| 07/18/2001 | EP1115878A1 Recombinant celo virus and celo virus dna |
| 07/18/2001 | EP1115864A2 Human chaperone proteins |
| 07/18/2001 | EP1115851A1 Method of screening for large offspring syndrome |
| 07/18/2001 | EP1115849A2 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 07/18/2001 | EP1115747A1 Polymer complexes of glucuronoglucanes |
| 07/18/2001 | EP1115735A1 31 human secreted proteins |
| 07/18/2001 | EP1115720A2 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/18/2001 | EP1115719A2 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 07/18/2001 | EP1115701A1 Arylsulfonanilide ureas |
| 07/18/2001 | EP1115697A1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 07/18/2001 | EP1115420A2 Treatment of hepatitis b infection with thymosin alpha 1 and lamivudine |
| 07/18/2001 | EP1115419A2 Carbapenem antibacterial compositions and methods of treatment |
| 07/18/2001 | EP1115418A2 Aglyco products and methods of use |
| 07/18/2001 | EP1115417A2 Methods for administration of antibiotics |
| 07/18/2001 | EP1115411A1 Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof |
| 07/18/2001 | EP1115398A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 07/18/2001 | EP1115397A1 Method of mitigating the adverse effects of interleukin-2 |
| 07/18/2001 | EP1115394A2 Pharmaceutical compositions comprising derivatives of sulphur acids |
| 07/18/2001 | EP1115392A2 Use of n-acylvanillinamide derivatives as agonists of peripheral cannabinoid cb1 receptors |
| 07/18/2001 | EP1115388A1 Use of organophosphorous compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants |
| 07/18/2001 | EP1115387A2 Anti-microbial-adhesion fraction derived from vaccinium |
| 07/18/2001 | EP1115382A2 Immunogenic liposome compositions |
| 07/18/2001 | EP1115380A2 Micronised pharmaceutical compositions |
| 07/18/2001 | EP1115372A2 Fast dissolving orally consumable films |
| 07/18/2001 | EP1115289A2 Environmentally benign crop protection agents |
| 07/18/2001 | EP1115286A1 Methods for treating or preventing viral infections and associated diseases |
| 07/18/2001 | EP1115285A1 Safe and effective biofilm inhibitory compounds and health-related uses thereof |
| 07/18/2001 | EP1115284A1 Antifouling agents |
| 07/18/2001 | EP1033369A4 5H-PYRANO [2,3-d:6,5-d']DIPYRIMIDINE DERIVATIVES HAVING AN ANTIBACTERIAL, ANTIVIRAL AND IMMUNO-MODULATING ACTIVITY |
| 07/18/2001 | EP0824539B1 Dialkyltiacumicin compounds |
| 07/18/2001 | EP0758235B1 Polymer coated tablet comprising amoxycillin and clavulanate |
| 07/18/2001 | EP0667787B1 Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines |
| 07/18/2001 | CN1304453A Vaccine-induced hepatitis B viral strain and uses thereof |
| 07/18/2001 | CN1304452A Attenuated pestiviruses |
| 07/18/2001 | CN1304451A Fusion proteins of i(mycobacterium tuberuculosis) antigens and their uses |
| 07/18/2001 | CN1304442A Delivery of proteins into eukaryotic cells with recombinant Yersinia |
| 07/18/2001 | CN1304413A Form VI5,6-dichloro-2-(isopropylamino)-1-(&beta-L-ribofuranosyl)-1H-benzimidazole |
| 07/18/2001 | CN1304412A Process for preparing crystalline salts of amoxycillin |
| 07/18/2001 | CN1304410A Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 07/18/2001 | CN1304317A Nucleic acid encoding hyaluronan synthase and method of use |
| 07/18/2001 | CN1303707A Compound tinae-eliminating liquor |
| 07/18/2001 | CN1303673A Application of sophocarpine in preparation of medicine for curing coxsackievirus B myocarditis and its preparation method |
| 07/18/2001 | CN1068602C Pyrimidine nucleoside derivatives |
| 07/18/2001 | CN1068592C Imidazole derivatives having affinity for alpha 2 receptors activity |
| 07/18/2001 | CN1068588C 1H-indole-3-acetamide splA2 inhibitors |
| 07/18/2001 | CN1068520C Garlic extract capsule and garlic powder capsule, and producing process thereof |
| 07/17/2001 | US6262244 Genes coding for the extracellular part of four specific nkg2 (natural killer) transmembrane proteins; useful in treating infectious diseases and cancer |
| 07/17/2001 | US6262243 Nucleic acids encoding antimicrobial peptides |
| 07/17/2001 | US6262111 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 07/17/2001 | US6262101 Alpha-pyrrolidine, imidazole and thiophene-substituted styrene derivatives; inhibitors of tumor necrosis factor alpha, nuclear factor kappa b, and phosphodiesterase |
| 07/17/2001 | US6262096 Aminothiazole inhibitors of cyclin dependent kinases |
| 07/17/2001 | US6262095 Use of tricyclic derivatives of 1,4-dihydro-1,4-dioxo-1H-naphthalene, novel compounds obtained and their application in theraphy |
| 07/17/2001 | US6262088 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 07/17/2001 | US6262052 Amino acid ester containing azole antifungals |
| 07/17/2001 | US6262046 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 07/17/2001 | US6262040 Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF) |
| 07/17/2001 | US6262016 Transferrin receptor genes |
| 07/17/2001 | US6261839 Method for the induction of a NK cell-mediated immune response |
| 07/17/2001 | US6261817 Guaa |
| 07/17/2001 | US6261806 Molecular sequence of swine retrovirus and methods of use |
| 07/17/2001 | US6261802 Ups (ugc) |
| 07/17/2001 | US6261801 Nucleic acids encoding tumor necrosis factor receptor 5 |
| 07/17/2001 | US6261799 Expression cassettes encoding soluble, non-cleavable, chimeric HIV-1 GP160 variants, their methods of construction, and methods for the production of GP160 variants |
| 07/17/2001 | US6261790 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 07/17/2001 | US6261787 Bifunctional molecules for delivery of therapeutics |
| 07/17/2001 | US6261571 Immunogenic compositions comprising dimeric forms of the human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus (SIV) envelope glycoproteins |
| 07/17/2001 | US6261570 Live attenuated virus vaccines for western equine encephalitis virus, eastern equine encephalitis virus, and venezuelan equine encephalitis virus IE and IIIA variants |
| 07/17/2001 | US6261568 Genetic engineering |
| 07/17/2001 | US6261567 Neutralizing antibodies |
| 07/17/2001 | US6261564 Medical diagnosis |
| 07/17/2001 | US6261563 Pseudorabies virus protein |
| 07/17/2001 | US6261561 Administering intimin or fusion protein |